Effects of sugammadex and rocuronium mast cell number and degranulation in rat liver

Anaesthesia

Volumn 67, Issue 10, 2012, Pages 1101-1104

  Tomak, Y ^a   Yalmaz A ^a   Bostan, H ^a   Tumkaya L ^a   Altuner, D ^a   Kalkan, Y ^a   Erdivanla B ^b  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^b Rize Education and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ROCURONIUM; SODIUM CHLORIDE; SUGAMMADEX; TRYPTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CONTROLLED STUDY; LIVER; MALE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PORTAL VEIN; RAT;

ALANINE TRANSAMINASE; ANDROSTANOLS; ANIMALS; ASPARTATE AMINOTRANSFERASES; CELL COUNT; CELL DEGRANULATION; GAMMA-CYCLODEXTRINS; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MAST CELLS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TRYPTASES;

EID: 84866053564     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2012.07264.x     Document Type: Article

References (22)

1. Heier T, Guttormsen AB,. Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: a report including 3 cases. Acta Anaesthesiologica Scandinavica 2000; 44: 775-81.
2. Mertes PM, Aimone-Gastin I, Guéant-Rodriguez RM, et al., Hypersensitivity reactions to neuromuscular blocking agents. Current Pharmaceutical Design 2008; 14: 2809-25.
3. Matthey P, Wang P, Finegan BA, et al., Rocuronium anaphylaxis and multiple neuromuscular blocking drug sensitivities. Canadian Journal of Anesthesia 2000; 47: 890-3.
4. Mertes PM, Laxenaire MC, Alla F,. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99: 536-45.
5. Rose M, Fisher M,. Rocuronium: high risk for anaphylaxis? British Journal of Anesthesia 2001; 86: 678-82.
6. Laxenaire MC, Mertes PM,. Anaphylaxis during anaesthesia. Results of a two-year survey in France. British Journal of Anaesthesia 2001; 87: 549-58.
7. de Boer HD, van Egmond J, van de Pol F, et al., Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys. British Journal of Anaesthesia 2006; 96: 201-6.
8. Gijsenbergh F, Ramael S, Houwing N, et al., First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103: 695-703.
9. Sorgenfrei IF, Norrild K, Larsen PB, et al., Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006; 104: 667-74.
10. Jones PM, Turkstra TP,. Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown. Anaesthesia 2010; 65: 89-90.
11. Funnell AE, Griffiths J, Hodzovic I,. A further case of rocuronium-induced anaphylaxis treated with sugammadex. British Journal of Anaesthesia 2011; 107: 275-6.
12. Menéndez-Ozcoidi L, Ortiz-Gõmez JR, Olaguibel-Ribero JM, et al., Allergy to low dose sugammadex. Anaesthesia 2011; 66: 217-9.
13. Payne V, Kam PC,. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 2004; 59: 695-703.
14. Okayama Y, Kawakami T,. Development, migration, and survival of mast cells. Immunologic Research 2006; 34: 97-115.
15. Hallgren J, Pejler G,. Biology of mast cell tryptase. An inflammatory mediator. Federation of European Biochemical Societies Journal 2006; 273: 1871-95.
16. Proost JH, Eriksson LI, Mirakhur RK, Roest G, Wierda JM,. Urinary, biliary and faecal excretion of rocuronium in humans. British Journal of Anaesthesia 2000; 85: 717-23.
17. Mirakhur RK,. Safety aspects of non-depolarizing neuromuscular blocking agents with special reference to rocuronium bromide. European Journal of Anaesthesiology 1994; 9: 133-40.
18. Clarke RC, Sadleir PHM, Platt PR,. The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model. Anaesthesia 2012; 67: 266-73.
19. Fisher MM, Baldo BA,. Mast cell tryptase in anaesthetic anaphylactoid reactions. British Journal of Anaesthesia 1998; 80: 26-9.
20. Dellon ES, Chen X, Miller CR, et al., Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. American Journal of Gastroenterology 2011; 106: 264-71.
21. Harper NJN,. A reply. Anaesthesia 2010; 65: 90.
22. Leysen J, Bridts CH, De Clerck LS, Ebo DG,. Rocuronium-induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment. Anaesthesia 2011; 66: 526-7.